Frequency-domain features
CWT extracts low-amplitude signals invisible to conventional ECG analysis, the patterns AI excels at.
MyoVista wavECG
A 12-lead ECG built for the AI era.
MyoVista wavECG is a portable, clinical-grade 12-lead ECG device that simplifies ECG acquisition, provides interoperability with third-party ECG management systems and EHR platforms, and supports AI-ECG algorithms directly on the device.
Device
Two tests in one.
Every wavECG recording produces a complete conventional 12-lead ECG with the highly-acclaimed Glasgow interpretive analysis, plus wavelet-domain features that AI-ECG algorithms can act on directly.
- Full-featured 12-lead resting ECG
- Glasgow interpretive analysis included
- Software-upgradable to host future AI-ECG algorithms
- Direct cloud sync to MyoVista Insights
Why CWT
Continuous wavelet transform: proprietary signal processing.
The wavECG device extracts proprietary frequency- and energy-domain features from the ECG that conventional analysis can't see.
Cardiac relaxation
The first AI-ECG algorithm slated for the wavECG submission targets impaired cardiac relaxation.
Future-ready
Architected so additional AI-ECG models, like aortic stenosis and mitral regurgitation, drop in over the air.
Get started
See wavECG in your clinic.
Walk through the platform with our team to see how to improve you ECG workflow.